Related Experiment Video
Updated: Apr 29, 2026
08:13
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
70.0K
Latinas with elevated fasting plasma glucose: an analysis using NHANES 2009-2010 data
Shiela M Strauss1, Marlena Vega, Helene D Clayton-Jeter
1New York University, USA.
Summary
Early detection of elevated fasting plasma glucose (FPG) is crucial for Latinas. Many are unaware of their diabetes risk and less likely to see healthcare providers, necessitating alternative screening methods.
Area of Science:
- Public Health
- Endocrinology
- Health Disparities
Background:
- Elevated fasting plasma glucose (FPG) indicates prediabetes or diabetes, requiring early detection for health optimization.
- In 2009-2010, 36.7% of US Latinas had elevated FPG levels.
- A significant number of Latinas with elevated FPG are unaware of their diabetes status.
Purpose of the Study:
- To highlight the urgent need for improved diabetes screening among Latinas.
- To underscore the disparity in healthcare access for Latinas with elevated FPG.
Main Methods:
- Analysis of data collected in 2009-2010.
- Comparison of healthcare provider visit rates between Latinas and other racial/ethnic groups.
Main Results:
- Latinas with undiagnosed elevated FPG were less likely to have seen a healthcare provider in the past year compared to non-Hispanic White and Black women (75.8% vs. 92.9% and 90.2%, respectively).
- Approximately 1 million Latinas in the US have elevated FPG and are unaware of their risk.
- A statistically significant difference (p = .018) was observed in healthcare access.
Conclusions:
- There is an urgent need for alternative diabetes screening sites for Latinas.
- Addressing healthcare access barriers is critical for early diabetes detection in this population.
- Targeted interventions are necessary to reduce diabetes-related health disparities in Latinas.
More Related Videos
04:54Using a Combination of Indirect Calorimetry, Infrared Thermography, and Blood Glucose Levels to Measure Brown Adipose Tissue Thermogenesis in Humans
Published on: June 2, 2023
3.5K
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
10.5K
Related Concept Videos
01:29Hyperglycemia
24
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
24
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
14
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
14
01:06Oral Hypoglycemic Agents: Glinides
1.0K
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
1.0K
01:16Hormones Regulating Blood Glucose
7.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.4K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
991
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
991
01:22Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K